Filing Details
- Accession Number:
- 0001181431-12-032171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-24 09:01:16
- Reporting Period:
- 2012-05-23
- Filing Date:
- 2012-05-24
- Accepted Time:
- 2012-05-24 09:01:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509725 | H. Michael Mulroy | 1300 North Kellogg Drive Suite D Anaheim CA 92807 | Sr Vp, Cfo & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-23 | 1,000 | $40.00 | 2,117 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- As of the date of this Form 4, the reporting person holds Questcor Pharmaceuticals, Inc. stock options to purchase 205,000 shares of common stock; of such amount, 41,666 shares are fully vested and exercisable.